In the human body, normal cell growth and differentiation are tightly regulated. In cancer cells, what key change occurs in these regulatory mechanisms?

Difficulty: Medium

Correct Answer: There is a breakdown of regulatory mechanisms leading to uncontrolled proliferation and formation of benign and malignant tumours

Explanation:


Introduction / Context:
Cancer is fundamentally a disease of abnormal cell growth and division. Under normal conditions, cells in the human body divide only when needed, and many internal checkpoints monitor DNA integrity and environmental signals. Cancer cells bypass these controls. This question asks you to identify the key change that occurs in regulatory mechanisms when cells become cancerous, leading to tumour formation.


Given Data / Assumptions:

  • The question contrasts normal regulated growth with changes seen in cancer.
  • Options mention breakdown of regulatory mechanisms, controlled division with excess genetic material, and reduced production of RNA or DNA.
  • We assume understanding that cancer is associated with uncontrolled growth, not simply with lower amounts of nucleic acids.


Concept / Approach:
Cancer arises when genetic and epigenetic alterations accumulate, affecting oncogenes, tumour suppressor genes, and DNA repair genes. These changes disrupt normal cell cycle control and apoptosis, allowing cells to divide without proper regulation and to survive when they should be eliminated. As a result, cell proliferation becomes uncontrolled, leading to the formation of masses of cells called tumours. Tumours can be benign, remaining localised, or malignant, invading nearby tissues and spreading to distant sites. The essential feature is the breakdown of regulatory mechanisms, not simply changes in the amount of DNA or RNA produced.


Step-by-Step Solution:
Step 1: Identify the hallmark of cancer as loss of control over cell growth and division. Step 2: Recognise that normal checkpoints in the cell cycle become ineffective due to mutations in key regulatory genes. Step 3: Understand that this loss of regulation leads to uncontrolled proliferation and tumour formation, including both benign and malignant tumours. Step 4: Choose the option that directly states the breakdown of regulatory mechanisms and the resulting formation of tumours, which matches the standard definition of cancer.


Verification / Alternative check:
Cancer biology textbooks highlight the hallmarks of cancer, which include sustained proliferative signalling, evasion of growth suppressors, resistance to cell death, and enabling of replicative immortality. All these hallmarks reflect disruption of normal regulatory pathways. While mutations in DNA are central, the key outcome is not reduced DNA quantity but altered control over cell behaviour. This perspective confirms that the important change is a breakdown of regulatory mechanisms leading to uncontrolled growth.


Why Other Options Are Wrong:

  • Controlled cell division and over production of genetic material: Cancer is defined by loss of control over division, not by division that remains controlled.
  • RNA mutated and produced in less amount: Cancer does involve mutations, but typically leads to abnormal or excessive signalling rather than reduced overall RNA output as the core feature.
  • DNA mutated and produced in less amount: Again, mutations are present, but the main problem is inappropriate growth and survival, not simply reduced DNA synthesis.


Common Pitfalls:
Students may focus only on the presence of mutations in cancer cells and forget that the defining consequence is disrupted regulation of the cell cycle and apoptosis. Another pitfall is thinking that cancer implies more DNA or less DNA, which may occur in some cases but is not the universal hallmark. Always connect cancer with uncontrolled proliferation and the ability of cells to form benign or malignant tumours despite the body's usual control mechanisms.


Final Answer:
In cancer cells, there is a breakdown of regulatory mechanisms leading to uncontrolled proliferation and formation of benign and malignant tumours.

Discussion & Comments

No comments yet. Be the first to comment!
Join Discussion